Journal Home
Search for

Volume 34, Issue 1, Pages 18-23 (January 2010)


View previous. 4 of 37 View next.

Expression and prognostic significance of the apoptotic genes BCL2L13, Livin, and CASP8AP2 in childhood acute lymphoblastic leukemia

Yung-Li Yangab, Shu-Rung Linc, Jiann-Shiuh Chendj, Shu-Wha Linef, Sung-Liang Yuaefg, Hsuan-Yu Chenh, Ching-Tzu Yenf, Chien-Yu Linh, Jing-Fang Linf, Kai-Hsin Linb, Shiann-Tarng Joub, Chung-Yi Huf, Sheng-Kai Changf, Meng-Yao Lub, Hsiu-Hao Changb, Wan-Hui Changi, Kuo-Sin Lini, Dong-Tsamn LinabCorresponding Author Informationemail address

Received 15 January 2009; received in revised form 12 July 2009; accepted 14 July 2009.

Abstract 

Improved treatment of childhood acute lymphoblastic leukemia (ALL) depends on the identification of new molecular markers that are able to predict treatment response and clinical outcome. The development of impaired apoptosis in leukemic cells is one factor that may influence their response to treatment. We investigated the expression of three apoptosis related genes, BCL2L13, CASP8AP2, and Livin, as well as their prognostic significance, in a retrospective study of 90 pediatric ALL patients diagnosed between 1996 and 2007 in Taiwan. Univariant analysis revealed that high expression of BCL2L13 was associated with inferior event-free survival and overall survival (p<0.001 and 0.005, respectively). Multivariate analysis for EFS and OS demonstrated that high expression of BCL2L13 was an independent prognostic factor for childhood ALL in this ethnic group.

a Department of Laboratory Medicine, College of Medicine, National Taiwan University, Taipei, Taiwan

b Department of Pediatrics, College of Medicine, National Taiwan University, Taipei, Taiwan

c Department of Bioscience Technology, College of Science, Chung-Yuan Christian University, Taoyuan, Taiwan

d Department of Internal Medicine, College of Medicine, National Taiwan University, Taipei, Taiwan

e Department of Medical Research, College of Medicine, National Taiwan University, Taipei, Taiwan

f National Taiwan University Hospital, Department of Clinical Laboratory Sciences and Medical Biotechnology, College of Medicine, National Taiwan University, Taipei, Taiwan

g NTU Center for Genomic Medicine, College of Medicine, National Taiwan University, Taipei, Taiwan

h Institute of Statistical Science Academia Sinica, Taiwan

i Taiwan Childhood Cancer Foundation, Taipei, Taiwan

j Department of Pediatrics, National Cheng Kung University Hospital, Tainan, Taiwan

Corresponding Author InformationCorresponding author at: Department of Laboratory Medicine and Pediatrics, National Taiwan University Hospital, College of Medicine, National Taiwan University, No. 7 Chung-San S. Rd., Sec. 1, Taipei 100, Taiwan. Tel.: +886 2 23123456x65399; fax: +886 2 23224263.

PII: S0145-2126(09)00370-1

doi:10.1016/j.leukres.2009.07.023


View previous. 4 of 37 View next.